Evidence map›Paper›PMID 34094845›Full record

ArticleProcedia CIRP2021

Challenging the engineering design process for the development of facial masks in the constraint of the COVID-19 pandemic.

Giovanni Formentini, Núria Boix Rodríguez, Claudio Favi, Marco Marconi

Open access · diamondAbstract read
In one paragraph

Article in Procedia CIRP, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Giovanni FormentiniDepartment of Engineering and Architecture, Università degli Studi di Parma, Parco Area delle Scienze 181/A, 43124, Parma, Italy.
Núria Boix RodríguezDepartment of Engineering and Architecture, Università degli Studi di Parma, Parco Area delle Scienze 181/A, 43124, Parma, Italy.
Claudio FaviDepartment of Engineering and Architecture, Università degli Studi di Parma, Parco Area delle Scienze 181/A, 43124, Parma, Italy.
Marco MarconiDepartment of Economics, Engineering, Society and Business Organization, Università degli Studi della Tuscia, Largo dell'Università, 01100, Viterbo, Italy.
University of Parma · ITUniversità degli Studi della Tuscia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The most effective ways to mitigate the diffusion of the COVID-19 pandemic are social distancing and the use of face masks as barrier to avoid droplets and to filtrate exhalations coming from infected subjects. Currently used face masks are products developed to be used by workers, both in health care and other contexts, where their use is limited in time and the disposal scenario is properly managed. Their use in a pandemic situation can be thus considered a remedial action due to the emergency. New masks or mask families are needed based on the desirable requirements retrieved by the analysis of the current worldwide situation and covering the gap observed in the market. The present paper aims to describe the complete product development process of a new facial mask (or mask family) for a daily use on a pandemic situation. It challenges the time constraint of the COVID-19 pandemic by adopting a four-step approach and concurrent development of the first phases (definition of requirements and functional derivation). The engineering design process allows to derive two different solutions able to fulfil all the requirements (demands and wishes) of final users, by assuring high ergonomic performance, as well as environmental, economic, and social sustainability.

Indexed as

COVID-19Engineering designfacial maskpandemicproduct development process

Identifiers

PMID34094845
PMCPMC8172034
OpenAlexW3166946678

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.